ciprofloxacin has been researched along with Conjunctivitis, Bacterial in 20 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Conjunctivitis, Bacterial: Purulent infections of the conjunctiva by several species of gram-negative, gram-positive, or acid-fast organisms. Some of the more commonly found genera causing conjunctival infections are Haemophilus, Streptococcus, Neisseria, and Chlamydia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study we investigate the emergence of fluoroquinolone (ciprofloxacin, levofloxacin) resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis." | 7.72 | Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. ( Alfonso, EC; Marangon, FB; Miller, D; Muallem, MS; Romano, AC, 2004) |
| " In this study we investigate the emergence of fluoroquinolone (ciprofloxacin, levofloxacin) resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis." | 3.72 | Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. ( Alfonso, EC; Marangon, FB; Miller, D; Muallem, MS; Romano, AC, 2004) |
| "Two study arms: 99 patients with bacterial conjunctivitis (A group) and 48 patients awaiting cataract surgery (B group--total 147 subjects in both groups) received ciprofloxacin 0." | 2.71 | [Clinical efficacy of ciprofloxacin 0.3%9 (Ciloxan) in the treatment of bacterial infections of the external eye segment]. ( Goś, A; Kosatka, M; Stankiewicz, A, 2003) |
| "This organism causes a non-specific purulent conjunctivitis that seems to have a benign course and tends to be responsive to a topical fluoroquinolone." | 1.43 | Four cases of Raoultella planticola conjunctivitis. ( Caruana, P; Cassar, R; Vassallo, J; Vella, M, 2016) |
| "In cases of unilateral purulent conjunctivitis, there should be a high clinical suspicion of GC, early swab for PCR and culture, and knowledge of current CDC-recommended antibiotic guidelines." | 1.42 | Prevalence of gonococcal conjunctivitis in adults and neonates. ( Cassidy, L; Curry, A; Knowles, SJ; McAnena, L, 2015) |
| "Oculoglandular tularemia is not only suspected in cases who complain of fever, cervical lymphadenopathy and purulent conjunctivitis, it should also be suspected in cases who are admitted to the hospital with acute dacryocystitis, which is a rare component of oculoglandular syndrome." | 1.39 | Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report. ( Celik, T; Kosker, M; Turkoglu, EB; Yuksel, D, 2013) |
| "Gatifloxacin showed lower resistance levels than moxifloxacin." | 1.38 | [In vitro antibiotic susceptibility to fluoroquinolones]. ( Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA, 2012) |
| "5%, wt/wt) showed optimum release and mucoadhesion properties and improved ocular bioavailability as evidenced by an enhanced therapeutic response compared with the marketed conventional eye drops." | 1.35 | Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels. ( Abd Elhady, SS; Mansour, M; Mansour, S; Mortada, ND, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lo, KBU | 1 |
| Azmaiparashvili, Z | 1 |
| Asbell, PA | 1 |
| DeCory, HH | 1 |
| Taubenslag, KJ | 1 |
| Michaels, MG | 1 |
| Sylvester, CL | 1 |
| Celik, T | 1 |
| Yuksel, D | 1 |
| Kosker, M | 1 |
| Turkoglu, EB | 1 |
| McAnena, L | 1 |
| Knowles, SJ | 1 |
| Curry, A | 1 |
| Cassidy, L | 1 |
| Vassallo, J | 1 |
| Vella, M | 1 |
| Cassar, R | 1 |
| Caruana, P | 1 |
| Mansour, M | 1 |
| Mansour, S | 1 |
| Mortada, ND | 1 |
| Abd Elhady, SS | 1 |
| D'Arienzo, PA | 1 |
| Wagner, RS | 1 |
| Jamison, T | 1 |
| Bell, B | 1 |
| Dajcs, JJ | 1 |
| Stroman, DW | 1 |
| Wong, CA | 1 |
| Galvis, V | 1 |
| Tello, A | 1 |
| Villareal, D | 1 |
| Rey, JJ | 1 |
| Charoo, NA | 2 |
| Kohli, K | 2 |
| Ali, A | 2 |
| Anwer, A | 1 |
| Chisari, G | 1 |
| Sanfilippo, M | 1 |
| Reibaldi, M | 1 |
| Marangon, FB | 1 |
| Miller, D | 1 |
| Muallem, MS | 1 |
| Romano, AC | 1 |
| Alfonso, EC | 1 |
| Stankiewicz, A | 1 |
| Kosatka, M | 1 |
| Goś, A | 1 |
| Marinkovic, M | 1 |
| Witmer, JP | 1 |
| Snyder-Perlmutter, LS | 1 |
| Katz, HR | 1 |
| Melia, M | 1 |
| Graves, A | 1 |
| Henry, M | 1 |
| O'Brien, TP | 1 |
| Hwang, DG | 1 |
| Van Buskirk, A | 1 |
| Trousdale, MD | 1 |
| Wittpenn, JR | 1 |
| Yolton, DP | 1 |
1 review available for ciprofloxacin and Conjunctivitis, Bacterial
| Article | Year |
|---|---|
New antibacterial drugs for topical ophthalmic use.
Topics: Ciprofloxacin; Conjunctivitis, Bacterial; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, | 1992 |
3 trials available for ciprofloxacin and Conjunctivitis, Bacterial
| Article | Year |
|---|---|
[Treatment of bacterial conjuntivitis with topical ciprofloxacin and norfloxacin: a comparative study].
Topics: Administration, Topical; Adult; Anti-Infective Agents; Ciprofloxacin; Conjunctivitis, Bacterial; Fem | 2003 |
[Clinical efficacy of ciprofloxacin 0.3%9 (Ciloxan) in the treatment of bacterial infections of the external eye segment].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cataract | 2003 |
Effect of topical ciprofloxacin 0.3% and ofloxacin 0.3% on the reduction of bacterial flora on the human conjunctiva.
Topics: Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Conjunctiva; Conjunctivi | 2000 |
16 other studies available for ciprofloxacin and Conjunctivitis, Bacterial
| Article | Year |
|---|---|
Desquamating pustular rash.
Topics: Acute Generalized Exanthematous Pustulosis; Administration, Topical; Aged; Anti-Bacterial Agents; Bi | 2019 |
Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Child; | 2018 |
A Child With Unilateral Conjunctivitis and Elevated Inflammatory Markers.
Topics: Anti-Bacterial Agents; Biomarkers; Blood Sedimentation; C-Reactive Protein; Child; Ciprofloxacin; Co | 2018 |
Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report.
Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Clavula | 2013 |
Prevalence of gonococcal conjunctivitis in adults and neonates.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Conjunctivit | 2015 |
Four cases of Raoultella planticola conjunctivitis.
Topics: Administration, Topical; Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; | 2016 |
Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
Topics: Adhesiveness; Animals; Anti-Infective Agents; Biological Availability; Cellulose; Ciprofloxacin; Con | 2008 |
Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteriological Techniques; Ciprofloxacin; Conjunctivitis, Bac | 2010 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; | 2012 |
Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies.
Topics: Algorithms; Animals; Anti-Infective Agents; Aqueous Humor; Chromatography, Thin Layer; Ciprofloxacin | 2003 |
Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Aqueous Humor; Chemistry, Pharmaceutical; C | 2003 |
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjunctivitis, Bacterial; Cross-Sectional Studies; Drug Resis | 2004 |
[Diagnostic image (299). An oncology patient suffering from conjunctivitis].
Topics: Anti-Infective Agents; Antineoplastic Agents; Antineoplastic Protocols; Carcinoma, Small Cell; Cipro | 2006 |
In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Conjunctivitis, Bacterial; | 2001 |
Effect of ciprofloxacin and ofloxacin on bacterial flora.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Conjunctiva; Conjunctivitis | 2001 |
Ophthalmic ciprofloxacin.
Topics: Ciprofloxacin; Conjunctivitis, Bacterial; Drug Resistance, Microbial; Eye Infections, Bacterial; Hum | 1991 |